Log In
Print this Print this

Exforge HCT

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionCombination of the calcium channel blocker amlodipine, the angiotensin receptor blocker valsartan and the diuretic hydrochlorothiazide
Molecular Target Angiotensin II type 1 (AT1) receptor (AGTR1) ; Calcium channel
Mechanism of ActionCalcium channel blocker; Angiotensin receptor blocker
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentMarketed
Standard IndicationHypertension
Indication DetailsTreat hypertension
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today